ERBB2 and breast carcinoma: In addition, exosomes painted with a dual antibody targeting CD3 T cells and breast cancer-associated HER2 receptors can recruit not only T cells but also induce specific killing of HER2-positive breast cancer cells (Huang et al., 2022).